Translate
Ronny Allan
I always try to use graphics for a number of pictures, I admit mainly to catch people’s attention but also because sometimes a picture on its own tells a story or at least provides a great introduction to one.
If the picture catches your eye, clicking on will take you to the text. This post will auto update as new blogs are published.
thanks for reading and sharing!

New PET findings after COVID-19 vaccination: Keep Calm and Carry On?

Clinical Trial: Triapine and Lutetium Lu 177 Dotatate for Neuroendocrine Tumors

CAPTEM for Neuroendocrine Tumours

Living with Cancer: Don’t cross the bridge until you come to it

Clinical Trial: Dostarlimab, anti–PD-1 monoclonal antibody in Neuroendocrine Carcinoma

Low and High Residue Foods

On the Cancer Journey, don’t forget to live your life

Histotripsy: A new technique which destroys cancer using soundwaves (now in Clinical Trials)

We are still here!

My invisible illness is not invisible to me

Electronic Autoinjector for Somatuline® Autogel® / Somatuline® Depot (lanreotide)

Clinical Trial: Mycapssa® (octreotide capsules) for Neuroendocrine Tumours

Clinical Trial: Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

A Spotlight on Lung Neuroendocrine Neoplasms

The trouble with the NET (Part 5) – Cancer Food Myths

External Validation of a Clinical Score for Patients With Neuroendocrine Tumors Under Consideration for Peptide Receptor Radionuclide Therapy

Clinical Trial: Lutathera and ASTX727 in Neuroendocrine Tumours (LANTana)

Blog review and top 10 for 2021: RonnyAllan.NET

Neuroendocrine Cancer Diarrhea- building the jigsaw: Bile Acid Malabsorption

177Lu-DOTA-LM3 – a novel radionuclide therapy proven safe and effective to treat neuroendocrine neoplasms (NEN)

Small Intestine Neuroendocrine Tumours: “No other cancer really looks like this”

20th November 2010 – feeling perkier

Do we need a new model for Carcinoid Crisis in NETs?

A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot (CAM2029) in Patients With GEP-NET (SORENTO)

CAR-T clinical trials for Neuroendocrine Cancer

Opinion: On World Neuroendocrine Cancer Day, what’s wrong with a bit of Neuroendocrine Cancer awareness?

In the land of small tumours, there is still a lot of work to do!

The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability

Q. The best diet for Neuroendocrine Cancer? A. The one that works for you.

Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) – (COMPOSE)

New Clinical Trial – Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

The GRAIL multi-cancer early detection test study

Neuroendocrine Tumors: Targeted Therapies – Update from NET Specialist Diane Reidy-Lagunes, MD, Memorial Sloan-Kettering Cancer Center – August 2021

UK Travel Insurance – are cancer patients a cash cow?

I thought I was going to die. I didn’t

Small Intestine Neuroendocrine Tumours (SI NETs): To cut or not to cut?

Cancer-related fatigue (CRF) – Neuroendocrine Cancer

Let’s Talk About NETs (#LetsTalkAboutNETs)

11 years – I’m still here!

Neuroendocrine Cancer: 48 hours before diagnosis

Every picture tells a story (point, click, read)

A person with Neuroendocrine Cancer fell into a hole and couldn’t get out……….

A painting from America

The 6 E’s

I have walked 500 miles and I will walk 500 more (….. sing along)

Clinical Trial: Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Neuroendocrine Tumour (VMT-𝛼-NET) programs

Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumours

Generic Somatostatin Analogues for Neuroendocrine Cancer

A Diagnostic Imaging Study of 64Cu-SARTATE™ for Neuroendocrine Tumours

A Neuroendocrine Cancer diagnosis: I didn’t even feel ill

Treatment for Neuroendocrine Cancer – a summary for patients

Ronny Allan Newsletter – 1st March 2021

Opinion: On Rare Disease Day, what’s wrong with a bit of Neuroendocrine Cancer awareness?

My treatment is a pain in the butt!

Ronny Allan – Top 10 for 2020 – Neuroendocrine Cancer

Neuroendocrine Cancer: Follow up tests and checks

Neuroendocrine Cancer – I didn’t hear it coming

Opinion: On World Cancer Day, what’s wrong with a bit of Neuroendocrine Cancer awareness?

Ronny Allan Newsletter – 1st February 2021

Lanreotide and Keytruda – the PLANET study (NCT03043664)

Currently trending on RonnyAllan.NET

The Invisibility of Appendiceal and Colorectal NETs – do the math

Ronny Allan Newsletter – 1st January 2021

A 2020 blog review (RonnyAllan.NET)

Genome methylation accurately predicts neuroendocrine tumor origin – finding Neuroendocrine Neoplasms of unknown primary

Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors – PRRT vs Everolimus

I will take the vaccine, no question

Neuroendocrine Tumours – now you see them, now you don’t!

Selecting patients and the Challenges of Evaluating Response to PRRT in GEPNETs: The Present and the Future

Lanreotide: Eleven more years please!

Thanks a MILLION …and then three quarters more!

Ronny Allan Newsletter 1st December 2020

If it’s not raining, it’s not training! (part 2)

Ronny Allan Newsletter 1st November 2020

Piss off cancer – I’m 66.5

Early diagnosis of late stage cancer!

Serotonin – it’s a no-brainer!

Paul Hunter Tribute – Snooker champion and Neuroendocrine Cancer patient

Ronny Allan Newsletter 1st October 2020

Clinical Trial: Phase II CLARINET FORTE Somatuline Autogel (Lanreotide) increased dosing frequency

I don’t look sick enough, sorry not sorry.

Clinical Trial of Tidutamab in Neuroendocrine Cancer (DUET-1)

“I’m vertical” – Steve Jobs announces to Apple staff after a liver transplant

Flower power and serotonin

1.4 million thanks!

RonnyAllan.NET – Newsletter 1st September 2020

Small intestine, large surgery

RonnyAllan.NET – Newsletter 1st August 2020

Paraneoplastic endocrine syndromes – the NET effect

10 years, I’m still here

Don’t be cavalier with a cancer diagnosis

Neuroendocrine Cancer – no sweat!

After lockdown – the new normal is not normal

Living with Neuroendocrine Cancer during COVID-19 restrictions (Episode 12) – a story of surviving, cycling, Scottish holiday memories including the ‘Fairy Pools’

The NETest® – a Chromogranin A replacement and more?

RonnyAllan.NET – Newsletter 1st July 2020

SSTR PET – Ga68-DOTA-JR11 vs Ga68-DOTATATE

Living with Neuroendocrine Cancer during COVID-19 restrictions (Episode 11) – a story of Walking the Wall, coping strategies and the London Ga68 PET

Targeted Therapy for Neuroendocrine Cancer – Sunitinib (Sutent)

Targeted Therapy for Neuroendocrine Cancer – Everolimus (Afinitor)

Ronny Allan: Living with Neuroendocrine Cancer during lockdown (Episode 10) – A story of the Wall, Swans, Dundee and New Forest History

My interview with ITM – I’m still here!

Ronny Allan: Living with Neuroendocrine Cancer during COVID-19 restrictions (Episode 9) – a story of cream teas, peaks and blue sky

RonnyAllan.NET – Newsletter 1st June 2020

Ronny Allan: Living with Neuroendocrine Cancer during COVID-19 restrictions (Episode 8) – a story of nurses, trees and Canada

Ronny Allan: Living with Neuroendocrine Cancer during lockdown restrictions (Episode 7) – A story of swans, cycling, VE Day and my 124th monthly cancer treatment

Ronny Allan: Living with Neuroendocrine Cancer during lockdown restrictions (Episode 6) – A story of footpath etiquette, sheep, donkeys and dopamine

Ronny Allan: Living with Neuroendocrine Cancer during lockdown (Episode 5) – A story of greenery, sun, adventure and Irrfan

Ronny Allan: Living with Neuroendocrine Cancer during COVID-19 restrictions (Episode 4) – A story of bikes, ponies, wisteria and Vitamin D

Ronny Allan: Living with Neuroendocrine Cancer during COVID-19 restrictions (Episode 3) – An injection, hair cut and a broken tooth

Ronny Allan: Living with Neuroendocrine Cancer during COVID-19 restrictions (Episode 2) – the bench walk

Ronny Allan: Living with Neuroendocrine Cancer during COVID-19 restrictions (Episode 1) – out of isolation

Neuroendocrine Cancer Surgery 3: my distant lymph nodes

We Remember – A message of hope in the time of the Coronavirus!

My Self Isolation Diary – COVID-19

COVID-19 and Cancer Treatment and Surveillance

Why Coronavirus Anxiety is Hard to Control – a Neuroendocrine Cancer patient perspective

Coronavirus 19 (COVID-19): risks for cancer patients

Neuroendocrine Cancer Nutrition Series Part 6 – featuring the 2020 video series by Tara Whyand RD

Clinical Trial: Lu-177 DOTATOC (PRRT) in adult subjects with Somatostatin receptor (SSTR) positive Pulmonary, Pheochromocytoma, Paraganglioma, Unknown primary, and Thymic Neuroendocrine Tumors

Oral Octreotide using RaniPill™

Neuroendocrine Cancer: The Perfect Storm

Neuroendocrine Cancer – Liver directed therapy

Featuring Kirsty Dalglish – Pheochromocytoma and Pregnancy

Ronny Allan – Top 10 for 2019 – Neuroendocrine Cancer

NETDetect: Earlier diagnosis of Neuroendocrine Cancer gets a boost

Prognostics and Crystal Balls

Olivia Williams – Neuroendocrine Cancer (VIPoma)

“Please find something wrong with me”

Neuroendocrine Cancer: Double, Double Toil and Trouble

The Flu shot – it’s not just about you

Clinical Trials – PEN-221 for Neuroendocrine Cancer

Clinical Trials – ONC201 for Neuroendocrine Cancer (including Pheo/Para)

The Other 5 E’s

The Case of Justice Ruth Bader Ginsburg vs Cancer

Surufatinib for Neuroendocrine Cancer

The trouble with the NET (Part 4) – Cancer can kill but so can fake cures

Pancreatic Neuroendocrine Tumours – to cut or not to cut

Clinical Trials of PV-10 (Rose Bengal) for the treatment of Neuroendocrine Tumours (NET)

New Radiotracer Can Identify Nearly 30 Types of Cancer – SNMMI – 68Ga-FAPI PET/CT

LUTATHERA (PRRT) – NETTER 2 Clinical Trial for Grade 2/Grade 3 Patients Advanced GEP-NET (NETTER-2)

Clinical Trial of Paltusotine for the Treatment of Neuroendocrine Tumours

The Heterogeneity of Grade 3 (High grade) Neuroendocrine Neoplasms

Clinical Trial: Treatment of IBS with diarrhoea – titrated ondansetron (TRITON)

I’m not sick, I just have cancer

Rosacea – the NET Effect

Neuroendocrine Cancer: No one gets it until they get it

From dying to living, to hell and back

“I Knew There Was Something Wrong, But I Didn’t Know What” — A Nurse Shares Her Cancer Story

Letter from America

Proton Pump Inhibitors (…..and H2 Blockers) the NET Effect

Clinical Trial: Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors (TALENT)

Clinical Trial: Intra-arterial Lu177 (PRRT) for Neuroendocrine Cancer liver metastases (LUTIA)

Clinical Trial SPARTALIZUMAB – Immunotherapy for Neuroendocrine Neoplasms (PDR001)

Breath test with the goal of detecting multiple cancers – ready to start trials

Q-Sphera™ – Next Generation Somatostatin Analogue delivery system?

Neuroendocrine Cancer: a needle in a haystack?

Neuroendocrine Cancer Clinical Trial – Lutetium-177 OPS-201 (Satoreotide)

RonnyAllan.NET – Community Newsletter Covering November 2018

Neuroendocrine Cancer – is normally slow growing BUT …..

Pancreatic Cancer vs Neuroendocrine Cancer of Pancreatic Origin

RonnyAllan.NET – Community Newsletter Covering October 2018

Neuroendocrine Cancer Hormonal Syndromes – Clinical Esoterica

How to Talk to a Cancer Patient Without Being a Complete Twit

Living with Cancer – Worrier or Warrior?

Neuroendocrine Cancer – Short Update from NANETS 2018

Neuroendocrine Cancer – on your bike!

RonnyAllan.NET – Community Newsletter Covering September 2018

Don’t worry, it’s benign!

Diabetes – The NET Effect

Neuroendocrine Cancer: Diagnosing the Undiagnosed

Neuroendocrine Cancer is not a ‘type’ of another Cancer ….. PERIOD!

RonnyAllan.NET – Community Newsletter Covering August 2018

Detectnet™ (64Cu-DOTATATE) – an expansion of the Somatostatin Receptor PET Imaging for Neuroendocrine Cancer

Aretha Franklin 1942-2018: Neuroendocrine Cancer

I wish I had another cancer

RonnyAllan.NET – Community Newsletter JULY 2018

Neuroendocrine Cancer: Ga68 PET Scan – a game changer?

Neuroendocrine Cancer: Fibrosis – an unsolved mystery?

“What are you doing this afternoon”

177Lu-DOTA-EB-TATE – Long-lasting radionuclide therapy for advanced neuroendocrine tumors proves effective

RonnyAllan.NET – Community Newsletter JUNE 2018

RonnyAllan.NET – Community Newsletter May 2018

All you need to know about Somatostatin Receptor PET/CT Scans for Neuroendocrine Tumours

RonnyAllan.NET – Community Newsletter April 2018

Sapanisertib – a drug on trial for Neuroendocrine Tumors (NET) with a pancreatic primary

RonnyAllan.NET – Community Newsletter March 2018

Irrfan Khan

RonnyAllan.NET – Community Newsletter February 2018

Update – Oncolytic Virus Trials for Neuroendocrine Cancer

Things to do today

Don’t be underactive with your Thyroid surveillance

Neuroendocrine Cancer Clinical Trial: Advanced Oncology Formula enterade®

RonnyAllan.NET – Community Newsletter January 2018

I now take food with my medicine!

BREAKING NEWS – US FDA Approves Lutetium Lu 177 dotatate (Lutathera®) – PRRT?

Shame on you!

Neuroendocrine Cancer and Pancreatic Enzyme Replacement Therapy (PERT) – the Digested Version (Nutrition Series Article 5)

Targeted Alpha-emitter Therapy (TAT) – the wave of the future in nuclear oncology/PRRT?

NETwork with Ronny © – Community Newsletter DECEMBER 2017

Ronny Allan – Top 6 posts of 2017

Neuroendocrine Cancer – surveillance and follow up

Update: Management of Neuroendocrine Tumors

Phase 3 Clinical Trial of 177Lu-Edotreotide (Solucin®) – COMPETE for GEPNETs

NETwork with Ronny © – Community Newsletter NOVEMBER 2017

Living with Neuroendocrine Cancer – the 7 Year Itch

NETwork with Ronny © – Community Newsletter OCTOBER 2017

Neuroendocrine Cancer – normally slow but always sneaky
Round up of NANETS 2017 – Let’s talk about NETs #NANETS2017

Opinion: Neuroendocrine Cancer – Can it be cured?

Weight – the NET Effect

The shock effect never wears off

Genetics and Neuroendocrine Tumors

Cancer Isn’t All About Me

NETwork with Ronny © – Community Newsletter SEPTEMBER 2017

Ever wonder what caused your Neuroendocrine Cancer?

Categories, tissues and primary sites – the lost awareness of Neuroendocrine Cancer

NETwork with Ronny © – Community Newsletter AUGUST 2017

The Invisible NET Patient Population

Lanreotide for Lung NETs – SPINET Clinical Trial

NETwork with Ronny © – Community Newsletter JULY 2017

At home with Lanreotide (….and Octreotide)

NETwork with Ronny © – Community Newsletter JUNE 2017

Immunotherapy: Studies with Neuroendocrine Neoplasms

Ronny Allan’s ‘PoNETry’ © – An Ode to Invisible Illness

Ronny Allan’s ‘PoNETry’ © – An Ode to Lanreotide

8 tips for conquering fear – Living with Neuroendocrine Cancer

NETwork with Ronny © – Community Newsletter MAY 2017

ASCO 2017 – Let’s talk about NETs #ASCO17

All you need to know about Peptide Receptor Radionuclide Therapy (PRRT)

NETwork with Ronny © – Newsletter April 2017

The trouble with the NET (Part 3) – Miracle Cures

Diagnosed with Neuroendocrine Cancer? – 10 questions to ask your doctor (and where to find a NET Specialist Worldwide)

Don’t believe the hype – Neuroendocrine Cancer Myths debunked

There’s no such thing as a ‘tickbox’ Neuroendocrine Cancer patient
NETwork with Ronny © – Newsletter March 2017

In the war on Neuroendocrine Cancer, let’s not forget to win the battle for better quality of life

Poker Face or Cancer Card?

NETwork with Ronny © – Newsletter February 2017

It’s been 10 years since I saw a scalpel (….but my surgeon is still on speed dial)

Recent Progress in NET Management – Positive presentation from Jonathan R Strosberg MD

25 Life Lessons From a Two-Time Cancer Survivor

Things not to say to someone with cancer

NETwork with Ronny © – Newsletter January 2017

Endoscopy for NETs – taking the camera to the tumour

Road ahead closed – Bowel Obstructions

Neuroendocrine Tumor Drug Clinical Trial – Cabozantinib (includes news on Pheochromoctyoma and Paraganglioma)

Theranostics for Neuroendocrine Cancer – A Find and Destroy Mission

Neuroendocrine Cancer: Nodes, Nodules, Lesions (and false alarms!)

Surgery for Neuroendocrine Neoplasms – to cut or not to cut?

Does your body now have an extra organ? The MESENTERY
NETwork with Ronny © – Newsletter December 2016

Somatostatin Analogues for Neuroendocrine Cancer: Lanreotide and Octreotide

Keep your lights burning

Neuroendocrine Tumours: a spotlight on Pheochromocytoma and Paraganglioma
Drum Roll – Ronny Allan wins WEGO Best in Show ‘Community’ 2016

Neuroendocrine – don’t let it be a Crisis

NETwork with Ronny © – Newsletter November 2016
NET Syndromes – chicken or egg?

Dear every cancer patient I ever took care of, I’m sorry. I didn’t get it.

Neuroendocrine Tumours (NET) – benign vs malignant

Happy Thanksgiving

Chemo or not Chemo – that is the question

Palliative Care – it might just save your life

“You must be doing OK, you’ve not had chemotherapy”

One every 2 hours

Neuroendocrine Cancer – If you can see it, you can detect it!

Neuroendocrine Cancer – Exciting Times Ahead!

Living with NETs – a patients included award winning site

Neuroendocrine Cancer: Hurry up and wait

Did you hear the one about the constipated NET patient?

Neuroendocrine Cancer – were you irritated by your misdiagnosis?

Steve Jobs – the most famous Neuroendocrine Cancer Ambassador we NEVER had
Neuroendocrine Cancer: Patient Power!

Neuroendocrine Cancer – tumour markers and hormone levels
“Not the Stereotypical picture of sick”
Procrastination – it’s a killer

Neuroendocrine Cancer – the diarrhea jigsaw

WEGO Health Patient Leader: Ronny Allan – Living with Neuroendocrine Cancer

Serotonin – the NET effect

Neuroendocrine Cancer – not average, just mean
Stop talking about it, just go do it!

Not every illness is visible

Neuroendocrine Cancer Nutrition Series Part 4 – Amines: Food for Thought?

Living with #Cancer – if you’re reading this, you’re surviving
Exercise and Cancer: Forward is Forward

Somatostatin Receptors

Neuroendocrine Cancer: Troublesome Thyroids

What you don’t know might kill you
Neuroendocrine Cancer – it can be ‘smoke and mirrors’
Intra-Operative RadioTheraphy (IORT) for Neuroendocrine Cancer – new landmark treatment launch

Let’s talk about living with NETs

Neuroendocrine Cancer: Make some noise for this silent cancer
It’s scary searching Cancer online

Living with Cancer – Turning points

The 5 E’s (of Carcinoid Syndrome)

Clinical Trial: PRRT and Chemo combination therapy

Don’t worry, I really am OK!

Neuroendocrine Cancer: I Can
Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me. Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional as they are not members of the private group or followers of my sites in any official capacity. Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Subscribe to my newsletter
Top 10 Posts & Pages in the last 48 hours (auto updates)
Thanks for reading.
I’m also active on Facebook. Like my page for even more news. Help me build up my new site here – click here and ‘Like’
Sign up for my newsletters – Click Here
My Diagnosis and Treatment History
Check out my online presentations
Check out my WEGO Health Awards
Like my new awareness page – click here or on the photo. (Like rather than follow please!)
Remember ….. in the war on Neuroendocrine Cancer, let’s not forget to win the battle for better quality of life!